PATHWAY BIOPHARMA LIMITED
Executive Summary
Pathway Biopharma Limited currently exhibits a stable financial position with positive net assets and liquidity ratios, reflecting low solvency risk. The company complies with filing requirements and is managed by a single controlling director, indicating sound governance. However, the decline in net assets and limited operational scale suggest a need for closer scrutiny of financial trends and business prospects before investment.
View Full Analysis Report →- Legal registered address
- 29 Morningside Grove Edinburgh United Kingdom EH10 5PX Copied!
Latest financial results as of 10 August 2025- Current assets
- £50.30k
- Fixed assets
- £2.84k
- Current creditors
- £14.27k
- Shareholders funds
- £38.79k
View full financial accounts- Current assets
- £50.30k
- Fixed assets
- £2.84k
- Current creditors
- £14.27k
- Shareholders funds
- £38.79k
- Company number
- SC677513 Copied!
Accounts
Latest annual accounts were to 31 October 2024
Next annual accounts are due by 31 July 2026
Company financial year end is on 31 October 2025
Confirmation statement
Latest confirmation statement statement dated 18 October 2024
Next statement due by 1 November 2025
Nature of business (SIC)
70229 - Management consultancy activities other than financial management
Latest company documents
| Date | Description |
|---|---|
| 18/04/2518 April 2025 | Micro company accounts made up to 2024-10-31 |
| 31/10/2431 October 2024 | Annual accounts for year ending 31 Oct 2024 |
| 30/10/2430 October 2024 | Confirmation statement made on 2024-10-18 with updates |
| 22/04/2422 April 2024 | Micro company accounts made up to 2023-10-31 |
| 29/11/2329 November 2023 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company